German genetic diagnostics firm Centogene has raised $28m in a funding round led by TVM Capital Life Science, and featuring participation from Careventures, CIC Capital and DPE Deutsche Private Equity. The company is developing an automated DNA test that can detect the presence of certain diseases such as cancer, diabetes, cardiovascular disease or Alzheimer’s disease.
German genetic diagnostics firm Centogene has raised $28m in a funding round led by TVM Capital Life Science, and featuring participation from Careventures, CIC Capital and DPE Deutsche Private Equity. Centogene, which is compiling a database of rare disease genotypes and phenotypes by conducting tests all over the world, has also taken on a investment consortium to further its expansion ambitions in countries including the US and China.